Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients : Annals of Surgery

Journal Logo

ORIGINAL ARTICLES

Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients

Bossola, Maurizio MD*; Muscaritoli, Maurizio MD†; Costelli, Paola PhD‡; Grieco, Gabriella MD†; Bonelli, Gabriella PhD‡; Pacelli, Fabio MD*; Fanelli, Filippo Rossi MD†; Doglietto, Giovanni Battista MD*; Baccino, Francesco Maria MD‡§

Author Information
Annals of Surgery 237(3):p 384-389, March 2003. | DOI: 10.1097/01.SLA.0000055225.96357.71

Abstract

Objective 

To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.

Summary Background Data 

Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer.

Methods 

Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed.

Results 

Muscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity.

Conclusions 

These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed.

© 2003 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid